Clinical phenotype and genotype of NPRL2-related epilepsy: Four cases reports and literature review

Seizure. 2024 Mar:116:100-106. doi: 10.1016/j.seizure.2023.09.003. Epub 2023 Sep 6.

Abstract

Background: NPRL2-related epilepsy, caused by pathogenic germline variants of the NPRL2 gene, is a newly discovered childhood epilepsy linked to enhanced mTORC1 signalling. However, the phenotype and genotype of NPRL2 variants are still poorly understood. Here, we summarize the association between the phenotype and genotype of NPRL2-related epilepsy.

Methods: A retrospective analysis was conducted for four Chinese children with epilepsy due to likely pathogenic NPRL2 variants identified through whole-exome sequencing (WES). Previous reports of patients with NPRL2-related epilepsy were reviewed systematically.

Results: One of our patients presented focal epilepsy involving the central region, which should be distinguished from self-limited epilepsy with centrotemporal spikes (SeLECTS). The four novel likely pathogenic NPRL2 variants consisted of two nonsense variants, one frameshift variant, and one copy number variant (CNV). Bioinformatics analysis revealed the two nonsense variants to be highly conserved and cause alterations in protein structure. Including our four cases, a total of 33 patients with NPRL2-related epilepsy have been identified to date. The most common presentation is focal epilepsy (70%), including sleep-related hypermotor epilepsy (SHE), temporal lobe epilepsy (TLE), and frontal lobe epilepsy (FLE). Infantile epileptic spasms syndrome (IESS) is also a notable feature of NPRL2-related epilepsy. Malformations of cortical development (MCD, 8/20), especially focal cortical dysplasia (FCD, 6/20), are common neuroimaging abnormalities. Two-thirds of the NPRL2 variants reported are loss of function (LoF) (14/21). Among these mutations, c.100C>T (p.Arg34*) and c.314T>C (p.Leu105Pro) have been detected in two families (likely due to a founder effect).

Conclusion: NPRL2-related epilepsy shows high phenotypic and genotypic heterogeneity. Our study expands the genotype spectrum of NPRL2-related epilepsy, and the phenotype of focal epilepsy involving the central region should be clearly distinguished with SeLECTS, with reference value for clinical diagnosis.

Keywords: Focal epilepsy; Genotype; NPRL2; Phenotype.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Child
  • Epilepsies, Partial* / diagnosis
  • Epilepsies, Partial* / genetics
  • Epilepsy, Reflex*
  • GTPase-Activating Proteins / genetics
  • Genotype
  • Humans
  • Phenotype
  • Retrospective Studies
  • Tumor Suppressor Proteins / genetics

Substances

  • GTPase-Activating Proteins
  • NPRL2 protein, human
  • Tumor Suppressor Proteins